Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,929,830
in 12 filings, $348K under 10b5-1 plans

Net +$2,318,700. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-01-24 GUALBERTO ANTONIO Head of Development & CMO Grant or award · Option to purchase common stock +100,000 100,000
2018-01-24 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +275,000 275,000
2017-08-22 WILSON TROY EDWARD President and CEO Exercise or conversion +27,985 $4.80 $134K 32,985
2017-08-22 WILSON TROY EDWARD President and CEO Exercise or conversion · Option to purchase common stock −27,985 92,015
2017-06-09 Stein Steven H Director Grant or award · Option to purchase common stock +10,000 10,000
2017-06-09 Malley Thomas Director Grant or award · Option to purchase common stock +10,000 10,000
2017-06-09 Hasnain Faheem Director Grant or award · Option to purchase common stock +10,000 10,000
2017-06-09 HOFFMAN ROBERT Director Grant or award · Option to purchase common stock +10,000 10,000
2017-04-21 WILSON TROY EDWARD President and CEO Exercise or conversion +5,000 $4.80 $24K 5,000
2017-04-21 WILSON TROY EDWARD President and CEO Exercise or conversion · Option to purchase common stock −5,000 120,000
2017-01-23 LIU YI Chief Scientific Officer Grant or award · Option to purchase common stock +63,000 63,000
2017-01-23 REN PINGDA SVP-Chemistry&Pharma Sciences Grant or award · Option to purchase common stock +55,000 55,000
2017-01-23 North Annette SVP, General Counsel Grant or award · Option to purchase common stock +72,000 72,000
2017-01-23 GUALBERTO ANTONIO Chief Medical Officer Grant or award · Option to purchase common stock +169,000 169,000
2017-01-23 HENSON HEIDI Chief Financial Officer Grant or award · Option to purchase common stock +100,000 100,000
2017-01-23 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +236,000 236,000
2017-01-03 Stein Steven H Director Grant or award · Option to purchase common stock +30,000 30,000
2017-01-03 Stein Steven H Director Grant or award · Option to purchase common stock +3,333 3,333
2016-05-12 Malley Thomas Director Grant or award · Option to purchase common stock +10,000 10,000
2016-05-12 HOFFMAN ROBERT Director Grant or award · Option to purchase common stock +10,000 10,000

Page 20 of 21 · 417 trades